Ipilimumab has 1 known drug interaction based on U.S. FDA drug labeling data. 1 are classified as major interactions requiring close medical supervision. Notable interactions include combinations with Vemurafenib. Patients taking Ipilimumab should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 1
- Major
- 1
Major (1)
- Ipilimumab + Vemurafenib— Concurrent use increases transaminases and bilirubin in majority of patients. Increased hepatotoxicity risk.